Drug reference

sutimlimab-jome

Mosby’s 2024 Nursing Drug Reference

Source: Mosby’s 2024 Nursing Drug Reference
PDF pages: 1415

Review source pages for extracted sections and age labels.

Overview

Names and pronunciation

Enjaymo

PDF page 1415

Functional class

Func. class.: Antineoplastic/immuno- modulating agent

PDF page 1415

Uses

USES: Cold agglutinin disease to de- crease the need for red blood cell trans- fusion due to hemolysis

PDF page 1415

Dose and formulations

Dosage and routes

DOSAGE AND ROUTES Adults weighing ≥75 kg: IV 7500 mg once a week for 2 wk, then q2wk Adults weighing 39-74 kg: IV 6500 mg once a week for 2 wk then q2wk

PDF page 1415

Available forms

Available forms: Solution for injection 1100 mg/22 mL

PDF page 1415

Age labels are extracted for navigation. Check the complete source section and current local guidance before clinical use.

Drug reference

sutimlimab-jome

Mosby’s 2024 Nursing Drug Reference

Source: Mosby’s 2024 Nursing Drug Reference
PDF pages: 1415

Review source pages for extracted sections and age labels.

Overview

Names and pronunciation

Enjaymo

PDF page 1415

Functional class

Func. class.: Antineoplastic/immuno- modulating agent

PDF page 1415

Uses

USES: Cold agglutinin disease to de- crease the need for red blood cell trans- fusion due to hemolysis

PDF page 1415

Dose and formulations

Dosage and routes

DOSAGE AND ROUTES Adults weighing ≥75 kg: IV 7500 mg once a week for 2 wk, then q2wk Adults weighing 39-74 kg: IV 6500 mg once a week for 2 wk then q2wk

PDF page 1415

Available forms

Available forms: Solution for injection 1100 mg/22 mL

PDF page 1415

Age labels are extracted for navigation. Check the complete source section and current local guidance before clinical use.

sutimlimab-­jome

Overview

Names and pronunciation

Functional class

Uses

Dose and formulations

Dosage and routes

Available forms

sutimlimab-­jome

Overview

Names and pronunciation

Functional class

Uses

Dose and formulations

Dosage and routes

Available forms

sutimlimab-jome

sutimlimab-jome